GSK releases Synflorix, pediatric pneumococcal vaccine, in Korea

Published: 2010-08-03 06:57:00

Updated: 2010-08-03 06:57:00

GlaxoSmithKline (GSK) said it has supplied to the domestic hospitals and clinics its Synflorix a paediatric pneumococcal vaccine to protect against life-threatening diseases such as meningitis and bacteraemic pneumonia, as well as middle ear infections.

GSK’s new vaccine indicated for active immunization against invasive disease and acute otitis media (AOM) caused by Streptococcus pneumoniae...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.